Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nancy Cox, Matthew Ellis, John Bishop

Premium

Vanderbilt University has appointed Nancy Cox the founding director of the new Vanderbilt Genetics Institute, effective Jan. 1, 2015. She also will be a professor of genetics and direct the division of genetic medicine in the department of medicine.
Cox is currently a professor of medicine and human genetics and the chief of the section of genetic medicine at the University of Chicago.


The Baylor College of Medicine has named Matthew Ellis the newest McNair Scholar, a program that identifies researchers in breast and pancreatic cancer, juvenile diabetes, and neuroscience.

Ellis joined Baylor in September to direct the Lester and Sue Smith Breast Center. He is also a funded scholar of the Cancer Prevention and Research Institute of Texas and the Susan G. Komen Foundation for the Cure, and serves as a professor of medicine and as a member of the National Cancer Institute-designated Dan L. Duncan Cancer Center at Baylor. Prior to joining Baylor, Ellis served as professor of medicine, head of breast oncology, and head of medical oncology at Washington University School of Medicine. He was also previously on the faculty at Duke University and Georgetown University.


Veracyte has appointed Cepheid Chairman and CEO John Bishop to its board of directors. He also will join the board's compensation committee. Bishop replaces Samuel Colella, who resigned from the board, effective Nov. 30.

Bishop has a long track record in the molecular diagnostics industry, previously serving as president and CEO of Vysis, which was acquired by Abbott Laboratories; chairman and CEO of MicroProbe; and president and COO of Gen-Probe.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.